Benjamin Perry
Impact in
-
- Computational Drug Discovery Methods
- Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Synthesis and biological activity
- Synthesis and Properties of Aromatic Compounds
- Synthesis of heterocyclic compounds
- Synthesis and Characterization of Heterocyclic Compounds
Papers in
-
- Computational Drug Discovery Methods 10
-
- Synthesis and Characterization of Heterocyclic Compounds 3
- Synthesis and biological activity 3
- Synthesis and Properties of Aromatic Compounds 2
- Asymmetric Synthesis and Catalysis 2
- Co-authors
- Colin R. Groom (1 shared paper)William R. Pitt (1 shared paper)David M. Parry (1 shared paper)D. Christopher Braddock (4 shared papers)Kirandeep Samby (2 shared papers)Nir London (1 shared paper)Ed Griffen (1 shared paper)Annette von Delft (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)ACS Infectious Diseases (4 papers)RSC Medicinal Chemistry (2 papers)ChemMedChem (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Benjamin Perry
29 papers receiving 1.2k citations
Benjamin Perry's Hit Papers
Peers
Comparison fields: 5 of 86
- Computational Theory and Mathematics 345
- Organic Chemistry 416
- Microbiology 11
- Infectious Diseases 172
- Nephrology 51
Countries citing papers authored by Benjamin Perry
This map shows the geographic impact of Benjamin Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Perry more than expected).
Fields of papers citing papers by Benjamin Perry
This network shows the impact of papers produced by Benjamin Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Perry. The network helps show where Benjamin Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 285 | |
| 2 | 2021 | 197 | |
| 3 | Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Hit paper breakdown → | 2023 | 126 |
| 4 | AI is a viable alternative to high throughput screening: a 318-target study Hit paper breakdown → | 2024 | 92 |
| 5 | 2022 | 77 | |
| 6 | 2002 | 64 | |
| 7 | 2007 | 58 | |
| 8 | 2021 | 58 | |
| 9 | 2004 | 40 | |
| 10 | 2022 | 32 | |
| 11 | 2003 | 27 | |
| 12 | 2021 | 25 | |
| 13 | 2023 | 23 | |
| 14 | 2022 | 22 | |
| 15 | 2021 | 21 | |
| 16 | 2008 | 18 | |
| 17 | 2008 | 14 | |
| 18 | 2008 | 10 | |
| 19 | 2013 | 6 | |
| 20 | 2023 | 6 |
About Benjamin Perry
Benjamin Perry is a scholar working on Computational Theory and Mathematics, Organic Chemistry, Infectious Diseases, Epidemiology and Physical and Theoretical Chemistry, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (10 papers), Trypanosoma species research and implications (5 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), Synthesis and biological activity (3 papers), Research on Leishmaniasis Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Synthesis and Properties of Aromatic Compounds (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). The work is most often cited by research in Computational Theory and Mathematics (345 citations), Organic Chemistry (416 citations), Microbiology (11 citations), Infectious Diseases (172 citations) and Nephrology (51 citations). Benjamin Perry has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Colin R. Groom, William R. Pitt, David M. Parry, D. Christopher Braddock, Kirandeep Samby, Nir London, Ed Griffen, Annette von Delft, Matthew H. Todd and Mark Calmiano. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Infectious Diseases, RSC Medicinal Chemistry, ChemMedChem and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.